کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
10758787 | 1050412 | 2013 | 6 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Cleavage of the interchain disulfide bonds in rituximab increases its affinity for FcγRIIIA
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
ADCCmAbRTXFcγRGranzyme Binterchain disulfide bondFcγRIIIaSDS–PAGE - SDS-PAGEMonoclonal antibody - آنتی بادی مونوکلونالantibody-dependent cellular cytotoxicity - آنتی بادی-وابسته به سمیت سلولی سلولیsodium dodecyl sulfate–polyacrylamide gel electrophoresis - الکتروفورز ژل دوده سولفات سدیم پلی آکریل آمیدEffector function - تابع افترتورRituximab - ریتوکسیمابFcγ receptor - گیرنده Fcγ
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
زیست شیمی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Cleavage of the interchain disulfide bonds in rituximab increases its affinity for FcγRIIIA Cleavage of the interchain disulfide bonds in rituximab increases its affinity for FcγRIIIA](/preview/png/10758787.png)
چکیده انگلیسی
The Fc region of human IgG1 mediates effector function via binding to Fcγ receptors and complement activation. The H and L chains of IgG1 antibodies are joined by four interchain disulfide bonds. In this study, these bonds within the therapeutic IgG1 rituximab (RTX) were cleaved either by mild reduction followed by alkylation or by mild S-sulfonation; consequently, two modified RTXs - A-RTX (alkylated) and S-RTX (S-sulfonated) - were formed, and both were almost as potent as unmodified RTX when binding CD20 antigen. Unexpectedly, each modified RTX had a higher binding affinity for FcγRIIIA (CD16A) than did unmodified RTX. However, S-RTX and A-RTX were each less potent than RTX in an assay of antibody-dependent cellular cytotoxicity (ADCC). In this ADCC assay, each modified RTX showed decreased secretion of granzyme B, but no change in perforin secretion, from effector cells. These results provide significant information on the structures within IgG1 that are involved in binding FcγRIIIA, and they may be useful in the development of therapeutic antagonists for FcγRIIIA.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biochemical and Biophysical Research Communications - Volume 436, Issue 3, 5 July 2013, Pages 519-524
Journal: Biochemical and Biophysical Research Communications - Volume 436, Issue 3, 5 July 2013, Pages 519-524
نویسندگان
Mami Suzuki, Ayaka Yamanoi, Yusuke Machino, Eiji Kobayashi, Kaori Fukuchi, Mitsutoshi Tsukimoto, Shuji Kojima, Junya Kohroki, Kazunori Akimoto, Yasuhiko Masuho,